Alkermes (ALKS) net assets (shareholders' equity)

Net assets · fiscal 2025
$1.82B

Alkermes (ALKS) had net assets of $1.82B at the end of fiscal 2025 (December 31, 2025). That is 24.2% higher than the $1.46B of fiscal 2024. Figures as of 19 Nov 2026, 11:36 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
$1.82B
Change on fiscal 2024
+24.2%
Growth, 5 years
+11.3% a year
Growth, 10 years
+3.3% a year
Highest on record
$1.82Bfiscal 2025
Lowest on record
$392.02Mfiscal 2011
Fiscal years on record
172010–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Alkermes net assets (shareholders' equity), in more detail

Over the five fiscal years to 2025 net assets grew at a compound 11.3% a year; over ten years the rate was 3.3% a year. Across the 17 fiscal years on record (2010–2025), the highest was $1.82B in fiscal 2025 and the lowest $392.02M in fiscal 2011.

History · 17 fiscal years

Net assets by fiscal year

Alkermes net assets (shareholders' equity), year by year

Alkermes (ALKS) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$1.82B 24.2% up
2024$1.46B 21.8% up
2023$1.20B 15.2% up
2022$1.04B 6.2% down
2021$1.11B 4.3% up
2020$1.07B 1.7% down
2019$1.09B 7.3% down
2018$1.17B 2.6% down
2017$1.20B 0.6% down
2016$1.21B 8.0% down
2015$1.31B 5.9% down
2014$1.40B 31.1% up
2013$1.07B—
2013$952.37M 11.5% up
2012$853.85M 117.8% up
2011$392.02M 5.0% down
2010$412.62M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Alkermes and comparable companies
CompanyNet assetsFiscal year
Alkermes ALKS$1.82B2025
PACS Group PACS$946.77M2025
Kiniksa Pharmaceuticals International KNSA$567.61M2025
ImmunityBio IBRX-$500.47M2025
Cytokinetics CYTK-$659.63M2025
ABIVAX ABVX€455.21M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ALKS

Alkermes, figure by figure

Alkermes (ALKS) overview: price, valuation and scorecardAll health care companies by market value

Alkermes net assets (shareholders' equity): questions and answers

What are Alkermes's net assets?

Alkermes (ALKS) had net assets of $1.82B at the end of fiscal 2025 (December 31, 2025). That is 24.2% higher than the $1.46B of fiscal 2024.

What is the growth rate of Alkermes's net assets?

Over the five fiscal years to 2025 net assets grew at a compound 11.3% a year; over ten years the rate was 3.3% a year.

What are the highest and lowest net assets figures on record for Alkermes?

Across the 17 fiscal years on record (2010–2025), the highest was $1.82B in fiscal 2025 and the lowest $392.02M in fiscal 2011.

How is Alkermes's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Alkermes it is on record here for 17 fiscal years, 2010 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Alkermes (ALKS) net assets (shareholders' equity)”, data as of 19 November 2026. https://funkfolio.com/stock/ALKS/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.